Evidence map›Paper›PMID 35264662›Full record

ArticleScientific reports2022

A LexAop > UAS > QUAS trimeric plasmid to generate inducible and interconvertible Drosophila overexpression transgenes.

Franz Wendler, Sangbin Park, Claire Hill, Alessia Galasso, Kathleen R Chang, Iman Awan, Yulia Sudarikova, Mar Bustamante-Sequeiros, Sichen Liu, Ethan Y-H Sung and 3 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Article
  3. Identification ofFrontiers in immunology · 2026
    Review
  4. Article
  5. Article
  6. Expanding theeLife · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 2 countries.

Franz Wendler *Sir William Dunn School of Pathology, University of Oxford, South Parks Road, Oxford, UK.
Sangbin Park *Department of Developmental Biology, Stanford University School of Medicine, Stanford, CA, USA.
Claire HillSir William Dunn School of Pathology, University of Oxford, South Parks Road, Oxford, UK.
Alessia GalassoSir William Dunn School of Pathology, University of Oxford, South Parks Road, Oxford, UK.
Kathleen R ChangDepartment of Developmental Biology, Stanford University School of Medicine, Stanford, CA, USA.
Iman AwanSir William Dunn School of Pathology, University of Oxford, South Parks Road, Oxford, UK.
Yulia SudarikovaSir William Dunn School of Pathology, University of Oxford, South Parks Road, Oxford, UK.
Mar Bustamante-SequeirosSir William Dunn School of Pathology, University of Oxford, South Parks Road, Oxford, UK.
Sichen LiuSir William Dunn School of Pathology, University of Oxford, South Parks Road, Oxford, UK.
Ethan Y-H SungSir William Dunn School of Pathology, University of Oxford, South Parks Road, Oxford, UK.
Gabrielle Aisa-BonokoSir William Dunn School of Pathology, University of Oxford, South Parks Road, Oxford, UK.
Seung K KimDepartment of Developmental Biology, Stanford University School of Medicine, Stanford, CA, USA. seungkim@stanford.edu.
Luis A Baena-LopezSir William Dunn School of Pathology, University of Oxford, South Parks Road, Oxford, UK. alberto.baenalopez@path.ox.ac.uk.
University of Oxford · GBStanford University · US

Funding

Stanford Islet Research CoreP30DK116074 · NIDDK · STANFORD UNIVERSITY · PI Seung K Kim · 2017 to 2026
$19.5M
Therapeutic targeting of human islets with recombinant regulatory T cellsU01DK123743 · NIDDK · STANFORD UNIVERSITY · PI KIM, SEUNG K, MEYER, EVERETT · 2019 to 2022
$2.9M
Regulation of gastrointestinal hormone signaling and metabolism by Neuromedin UR01DK107507 · NIDDK · STANFORD UNIVERSITY · PI KIM, SEUNG K · 2017 to 2021
$2.0M
Discovering genetic and hormonal mechanisms underlying diabetes risk from flies to humansR01DK108817 · NIDDK · STANFORD UNIVERSITY · PI KIM, SEUNG K · 2018 to 2022
$2.0M
Biotechnology and Biological Sciences Research Council BB/M011224/1Cancer Research UK 17516Cancer Research UK C49979/A17516NIDDK NIH HHS P30 DK116074NIDDK NIH HHS R01 DK107507NIDDK NIH HHS R01 DK108817NIDDK NIH HHS U01 DK123743
6 · The paper itself

Abstract

The existence of three independent binary systems for conditional gene expression (Gal4/UAS; LexA/LexAop; QF/QUAS) has greatly expanded versatile genetic analyses in the Drosophila melanogaster; however, the experimental application of these tools is limited by the need to generate multiple collections of noninterchangeable transgenic fly strains for each inducible gene expression system. To address this practical limitation, we developed a modular vector that contains the regulatory elements from all three binary systems, enabling Gal4-, LexA- or QF-dependent expression of transgenes. Our methods also incorporate DNA elements that facilitate independent site-specific recombination and elimination of regulatory UAS, LexAop or QUAS modules with spatial and temporal control, thus offering unprecedented possibilities and logistical advantages for in vivo genetic modulation and efficient interconversion of overexpression transgenic fly lines.

Indexed as

DrosophilaDrosophila ProteinsAnimalsAnimals, Genetically ModifiedDrosophila melanogasterPlasmidsTransgenesDrosophila Proteins

Identifiers

PMID35264662
PMCPMC8907290
OpenAlexW4220903402

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.